Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 711 (USA) (Dr. Jansen)
· consented 2012-07-29
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild EAR INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-04 (study day 7.0); relationship: NONE
mild
assessed
2026-08-18
Mild EAR INFECTION — outcome: RECOVERED/RESOLVED; onset 2012-08-04 (study day 7.0); relationship: NONE
mild
assessed
2026-08-18
Mild GLOSSITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-12 (study day 15.0); relationship: NONE
mild
assessed
2026-08-18
Mild HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-07-29 (study day 1.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.